Ensign Peak Advisors’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $566K | Hold |
98,806
| – | – | ﹤0.01% | 1522 |
|
|
2025
Q1 | $806K | Hold |
98,806
| – | – | ﹤0.01% | 1372 |
|
|
2024
Q4 | $931K | Hold |
98,806
| – | – | ﹤0.01% | 1364 |
|
|
2024
Q3 | $1.06M | Hold |
98,806
| – | – | ﹤0.01% | 1294 |
|
|
2024
Q2 | $980K | Hold |
98,806
| – | – | ﹤0.01% | 1290 |
|
|
2024
Q1 | $1.16M | Sell |
98,806
-4,984
| -5% | -$58.7K | ﹤0.01% | 1219 |
|
|
2023
Q4 | $1.47M | Hold |
103,790
| – | – | ﹤0.01% | 1096 |
|
|
2023
Q3 | $1.26M | Hold |
103,790
| – | – | ﹤0.01% | 1026 |
|
|
2023
Q2 | $1.3M | Buy |
103,790
+4,300
| +4% | +$54K | ﹤0.01% | 1064 |
|
|
2023
Q1 | $1.1M | Hold |
99,490
| – | – | ﹤0.01% | 1163 |
|
|
2022
Q4 | $1.21M | Buy |
99,490
+43,200
| +77% | +$527K | ﹤0.01% | 1025 |
|
|
2022
Q3 | $588K | Sell |
56,290
-177,269
| -76% | -$1.85M | ﹤0.01% | 1371 |
|
|
2022
Q2 | $2.51M | Buy |
233,559
+177,429
| +316% | +$1.91M | 0.01% | 724 |
|
|
2022
Q1 | $532K | Buy |
56,130
+10,130
| +22% | +$96K | ﹤0.01% | 1531 |
|
|
2021
Q4 | $531K | Buy |
+46,000
| New | +$531K | ﹤0.01% | 1607 |
|
|
2021
Q1 | – | Sell |
-117,502
| Closed | -$2.71M | – | 1843 |
|
|
2020
Q4 | $2.71M | Sell |
117,502
-12,605
| -10% | -$291K | 0.01% | 882 |
|
|
2020
Q3 | $1.84M | Buy |
130,107
+124,019
| +2,037% | +$1.75M | ﹤0.01% | 1012 |
|
|
2020
Q2 | $92K | Hold |
6,088
| – | – | ﹤0.01% | 1634 |
|
|
2020
Q1 | $56K | Sell |
6,088
-7,089
| -54% | -$65.2K | ﹤0.01% | 1602 |
|
|
2019
Q4 | $129K | Buy |
+13,177
| New | +$129K | ﹤0.01% | 1637 |
|